Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Protein farnesyltransferase inhibitors disclosed by Schering-Plough

Jan. 8, 1998

Photofrin approval sought in nine additional European countries

Jan. 7, 1998

Theratechnologies to begin clinical testing of leukemia Rx

Jan. 7, 1998

More on peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

Jan. 7, 1998

MMP inhibitor developed at Chiroscience enters clinical trials for cancer

Jan. 5, 1998

Anti-GnRH immunogens disclosed by Aphton

Jan. 5, 1998

Polypeptide-chelating agent complexes reported by Novartis

Jan. 5, 1998

New photodynamic agents reported by Novartis

Dec. 31, 1997

Salagen Tablets enters phase III development in Japan

Dec. 30, 1997

Merck continues to pursue peptidomimetic farnesyltransferase inhibitors

Dec. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...